SEC Tracker
Get the app

Valion Bio VBIO

Valion Bio names Thomas Jensen as board chair

Form
8-K
Filed
Importance
Routine
  1. New board chair Thomas Jensen has 20+ years of biotech experience
  2. Entolimod has FDA Fast Track and Orphan Drug designations
  3. Valion received $35.6M in government funding for Entolimod
  4. Jensen led Allarity Therapeutics' refocusing on a single lead asset

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Valion Bio files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Healthy Extracts HYEX public float $4M, Jun 30, 2025
  2. Theriva Biologics TOVX public float $4M, Jun 30, 2025
  3. Jaguar Health JAGX public float $4M, Jun 30, 2025
  4. China Pharma Holdings CPHI public float $4M, Jun 30, 2025
  5. Synlogic SYBX public float $4M, Jun 30, 2025